FI965144A - Sterolijohdannaiset käytettäviksi meioosin säätelyyn - Google Patents

Sterolijohdannaiset käytettäviksi meioosin säätelyyn Download PDF

Info

Publication number
FI965144A
FI965144A FI965144A FI965144A FI965144A FI 965144 A FI965144 A FI 965144A FI 965144 A FI965144 A FI 965144A FI 965144 A FI965144 A FI 965144A FI 965144 A FI965144 A FI 965144A
Authority
FI
Finland
Prior art keywords
meiosis
regulation
sterol derivatives
derivatives
sterol
Prior art date
Application number
FI965144A
Other languages
English (en)
Swedish (sv)
Other versions
FI965144A0 (fi
FI117159B (fi
Inventor
Anne Grete Byskov
Claus Yding Andersen
Lars Nordholm
Henning Thoegersen
Ole Wassmann
Ivan Verner Diers
Erling Guddal
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of FI965144A0 publication Critical patent/FI965144A0/fi
Publication of FI965144A publication Critical patent/FI965144A/fi
Application granted granted Critical
Publication of FI117159B publication Critical patent/FI117159B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/001—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class spiro-linked
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Steroid Compounds (AREA)
  • Cosmetics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI965144A 1994-06-23 1996-12-20 Sterolijohdosten käyttö meioosin säätelyyn FI117159B (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
DK75394 1994-06-23
DK75394 1994-06-23
DK24195 1995-03-09
DK24195 1995-03-09
PCT/DK1995/000265 WO1996000235A1 (en) 1994-06-23 1995-06-23 Sterol derivatives used for regulation of meiosis
DK9500265 1995-06-23

Publications (3)

Publication Number Publication Date
FI965144A0 FI965144A0 (fi) 1996-12-20
FI965144A true FI965144A (fi) 1997-02-20
FI117159B FI117159B (fi) 2006-07-14

Family

ID=26063596

Family Applications (1)

Application Number Title Priority Date Filing Date
FI965144A FI117159B (fi) 1994-06-23 1996-12-20 Sterolijohdosten käyttö meioosin säätelyyn

Country Status (26)

Country Link
US (1) US5716777A (fi)
EP (1) EP0767798B1 (fi)
JP (1) JP3987105B2 (fi)
KR (1) KR100408369B1 (fi)
CN (1) CN1068333C (fi)
AT (1) ATE248852T1 (fi)
AU (1) AU694240B2 (fi)
BG (1) BG101067A (fi)
BR (1) BR9508074A (fi)
CA (1) CA2192941C (fi)
CZ (1) CZ289407B6 (fi)
DE (1) DE69531682T2 (fi)
DK (1) DK0767798T3 (fi)
ES (1) ES2204955T3 (fi)
FI (1) FI117159B (fi)
HU (1) HUT76343A (fi)
IL (1) IL114294A (fi)
IS (1) IS4404A (fi)
MX (1) MX9700174A (fi)
NO (1) NO314534B1 (fi)
PL (1) PL186688B1 (fi)
RU (1) RU2194510C2 (fi)
SI (1) SI9520077A (fi)
SK (1) SK165596A3 (fi)
UA (1) UA51622C2 (fi)
WO (1) WO1996000235A1 (fi)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19980702624A (ko) * 1995-03-06 1998-08-05 슈타르 피아 감수분열의 자극
CA2224866A1 (en) * 1995-06-23 1997-01-09 Novo Nordisk A/S Meiosis regulating compounds
US6645953B2 (en) * 1995-06-23 2003-11-11 Novo Nordisk A/S Meiosis regulating compounds
WO1997000883A1 (en) * 1995-06-23 1997-01-09 Novo Nordisk A/S Meiosis regulating compounds
AU746878B2 (en) 1996-12-20 2002-05-02 Novo Nordisk A/S Meiosis regulating compounds
KR20010012643A (ko) * 1997-05-16 2001-02-26 에프.지.엠. 헤르만스 20-아랄킬-5α-프레그난 유도체
EP0988312B1 (en) * 1997-06-04 2002-04-03 Akzo Nobel N.V. 17beta-allyloxy(thio)alkyl-androstane derivatives for the modulation of meiosis
WO1999032506A1 (en) * 1997-12-18 1999-07-01 Akzo Nobel N.V. 17β-ARYL (ARYLMETHYL) OXY(THIO)ALKYL -ANDROSTANE DERIVATIVES
BR9910415A (pt) * 1998-05-13 2001-01-09 Novo Nordisk As Novos compostos, uso de compostos, e, processo de regular a meiose
IL139241A0 (en) 1998-05-13 2001-11-25 Novo Nordisk As Meiosis regulating compounds
EP1098652A2 (en) * 1998-05-26 2001-05-16 Schering Aktiengesellschaft Treatment of infertility with camp-increasing compounds alone or in combination with at least one meiosis-stimulating compound
JP2003521444A (ja) * 1998-06-19 2003-07-15 ノボ ノルディスク アクティーゼルスカブ 減数分裂調節化合物
DK1137660T3 (da) * 1998-12-11 2003-02-03 Akzo Nobel Nv 22S-hydroxycholesta-8,14-dienderivater med meioseregulerende aktivitet
WO2000036132A1 (en) 1998-12-14 2000-06-22 Merck & Co., Inc. Hiv integrase inhibitors
WO2000047604A1 (en) * 1999-02-10 2000-08-17 Schering Aktiengesellschaft Unsaturated cholestane derivatives and their use for the preparation of meiosis regulating medicaments
EP1156822B1 (en) 1999-02-24 2006-02-08 Novo Nordisk A/S Iin vitro method for synchronisation of oocyte maturation
DE60034662T2 (de) * 1999-02-24 2008-01-03 Novo Nordisk A/S Behandlung von unfruchtbarkeit
JP2002537801A (ja) * 1999-02-26 2002-11-12 ノボ ノルディスク アクティーゼルスカブ 着床率を増大させる減数分裂活性化ステロール
EP1163258B1 (en) * 1999-03-09 2002-12-11 Akzo Nobel N.V. 22r-hydroxycholesta-8,14-diene derivatives for the inhibition of meiosis
WO2001019354A2 (en) * 1999-09-16 2001-03-22 Novo Nordisk A/S Composition for ivf
EP1127890A1 (en) 2000-02-22 2001-08-29 Schering Aktiengesellschaft Steroid derivatives with an additional ring annulated to ring A and use of these derivatives for the preparation of meiosis regulating medicaments
WO2001062260A2 (en) * 2000-02-25 2001-08-30 Schering Aktiengesellschaft Improvement of implantation rate
AU2001240624A1 (en) * 2000-02-25 2001-09-03 Novo-Nordisk A/S Improvement of implantation rate
JP2003533222A (ja) * 2000-05-18 2003-11-11 シエーリング アクチエンゲゼルシャフト 経年卵母細胞の受精
EP1245572A1 (en) 2001-03-26 2002-10-02 Schering Aktiengesellschaft Aminosterol compounds, their use in the preparation of meiosis-regulating medicaments and method for their preparation
WO2003070766A2 (en) * 2002-02-22 2003-08-28 Novo Nordisk A/S A transducer of mas signalling
US9376462B2 (en) 2010-10-01 2016-06-28 Indiana University Research And Technology Corporation Process for preparing delta-7,9(11) steroids from Ganoderma lucidum and analogs thereof
US9165822B2 (en) 2013-03-11 2015-10-20 Taiwan Semiconductor Manufacturing Company, Ltd. Semiconductor devices and methods of forming same
EA024619B1 (ru) * 2014-11-21 2016-10-31 Эльвин Гаджи оглы Керимли ФРАКСИНОСТЕРИН - 24β-ЭТИЛХОЛЕСТА-20-КАРБОКСИ-6(7),8(9)-ДИЕН 3β-ОЛА И ЕГО ПРОИЗВОДНОЕ

Also Published As

Publication number Publication date
CZ289407B6 (cs) 2002-01-16
IL114294A0 (en) 1995-10-31
NO314534B1 (no) 2003-04-07
AU694240B2 (en) 1998-07-16
SK165596A3 (en) 1997-08-06
NO965516D0 (no) 1996-12-20
IL114294A (en) 2002-09-12
EP0767798B1 (en) 2003-09-03
ES2204955T3 (es) 2004-05-01
MX9700174A (es) 1997-04-30
FI965144A0 (fi) 1996-12-20
HUT76343A (en) 1997-08-28
US5716777A (en) 1998-02-10
IS4404A (is) 1996-12-23
HU9603584D0 (en) 1997-02-28
SI9520077A (sl) 1998-06-30
EP0767798A1 (en) 1997-04-16
KR100408369B1 (ko) 2004-04-28
UA51622C2 (uk) 2002-12-16
CA2192941C (en) 2009-04-14
WO1996000235A1 (en) 1996-01-04
FI117159B (fi) 2006-07-14
BR9508074A (pt) 1997-08-12
DE69531682T2 (de) 2004-07-15
AU2734395A (en) 1996-01-19
CZ372596A3 (en) 1997-07-16
JPH10502060A (ja) 1998-02-24
CN1068333C (zh) 2001-07-11
RU2194510C2 (ru) 2002-12-20
DK0767798T3 (da) 2003-12-22
JP3987105B2 (ja) 2007-10-03
CA2192941A1 (en) 1996-01-04
PL186688B1 (pl) 2004-02-27
PL317830A1 (en) 1997-04-28
BG101067A (en) 1997-08-29
DE69531682D1 (de) 2003-10-09
ATE248852T1 (de) 2003-09-15
CN1151164A (zh) 1997-06-04
NO965516L (no) 1997-02-21

Similar Documents

Publication Publication Date Title
FI965144A (fi) Sterolijohdannaiset käytettäviksi meioosin säätelyyn
BG104247A (en) Resorcinol derivatives
FI972387A (fi) Iholle levitettäviä parasitisidikoostumuksia
BG99261A (en) Steroid glycosides for the treatment of hyperchlesterolemia
PT695758E (pt) Amidas e esteres de pentapeptidos inibidores de cancro humano
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
HRP930239A2 (en) Anti-inflamatory 4-aminophenol derivatives
DE69530403D1 (de) Analogen des keratinozytenwachstumfaktors
NO955141L (no) Reguleringsanordning for stol
DE69712900T2 (de) Nitratester von corticoid verbindungen und die therapeutische verwendungen davon
BG102250A (en) The use of marigold-extracted glycosides for the treatment of psoriasis
ATE203519T1 (de) Chinolinderivate als antimalariamittel
NO965444D0 (no) Triterpen-derivat samt medikamentell sammensetning omfattende dette
AR020563A1 (es) Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion
PL323235A1 (en) Derivatives of piperazine as neurokinin antagonists
ES2120667T3 (es) Sal de l-carnitina y composiciones cosmeticas y farmaceuticas que la contienen para tratamiento de dermatosis.
DK0773782T3 (da) Terpenderivater (sarcodictyiner) anvendelse som antitumormidler
DE69407057T2 (de) 1,3.5 (10) - estratriene derivate mit oraler wirkung
SE9504662D0 (sv) New compounds
UA42797C2 (uk) Похідні хінолон- і нафтиридонкарбонової кислоти та похідні ізоіндолу для їх одержання
DE69614552D1 (de) MODIFIZIERTE ALPHA-D-GLCP-(1,2)-ALPHA-D-Glcp-(1,3)-ALPHA-D-Glcp-ANALOGE
DK0967986T3 (da) Anvendelse af humant alfa1-surt glycoprotein til fremstilling af et farmaceutisk præparat
FI940088A0 (fi) Regleranordning/reglerdel foer spolvattenmnaengden i en vattenklosett
BR7502253U (pt) Arco dobrável para isolação de campo em tratamento odontológico
FI965187A0 (fi) 3-fenyyli-3-hydroksipiperidiinejä sisältäviä terapeuttisia koostumuksia

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 117159

Country of ref document: FI